Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

JD Sports confident for full year as sales jump

(Sharecast News) - Retailer JD Sports Fashion confirmed it was on track to meet full-year profits guidance on Wednesday, despite a "tough" trading environment. Sales at the fashion and sports specialist jumped 18% in the 26 weeks to 2 August, at £5.9bn, or by 20% at constant exchange rates.

Within that, organic sales in North America - JD Sports' biggest market - rose 3.1% at £2.3bn, and by 6% to £1.9bn in Europe.

In the UK, however, tough comparatives saw sales soften 1.7% to £1.5bn. The retailer benefited last year from strong demand during the Euro 2024 football tournament.

Group pre-tax profits fell to £351m from £406m, as the chain made controlled price investments, particularly online. It also makes the bulk of its profits in the second half.

Looking to the full year, JD Sports said it remained "cautious" on the trading environment, flagging consumer finances, a weaker jobs market and changes in the footwear product cycle.

However, the blue chip said the financial impact from US tariff exposure in the current year was likely to be limited.

As a result, it remained on track to meet forecasts for full-year pre-tax profits before adjusting items, despite the headwinds. Analysts are currently looking for annual profits of between £853m and £914m.

Regis Schultz, chief executive, said: "We delivered organic sales growth of 2.7% in the first half, in what remains a tough trading environment.

"This demonstrates the resilience of our business, underpinned by our agile multi-brand model, broad geographic reach and unmatched connection with customers."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.